Cart summary

You have no items in your shopping cart.

Lamifiban

SKU: orb1987066

Description

Lamifiban is a small molecule antagonist of the glycoprotein IIb/IIIa receptor, effectively inhibiting platelet aggregation. It is utilized in cardiovascular research, particularly in studies modeling thrombosis, and has been shown to reduce platelet consumption in experimental cardiopulmonary bypass procedures.

Research Area

Signal Transduction

Images & Validation

Key Properties

CAS Number144412-49-7
MW468.5
FormulaC24H28N4O6
SMILES[C@@H](C(=O)N1CCC(OCC(O)=O)CC1)(CC2=CC=C(O)C=C2)NC(=O)C3=CC=C(C(=N)N)C=C3
TargetIntegrin,Others

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Lamifiban trifluoroacetate [orb1987065]

    144412-50-0

    582.533

    C26H29F3N4O8

    100 mg, 50 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Lamifiban (orb1987066)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%